Synthesis of B-Arrestin D2 Biased Dopamine Agonist

Start Date

April 2024

Location

2nd floor - Library

Abstract

Aripiprazole is one of the most commonly prescribed antipsychotic drugs on the market that relies on dopamine receptor agonism as the mechanism of action. Derivatives of this compound including 7-(4-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)butoxy)-3,4-dihydroquinolin-2 (1H)-one, have been studied and found to be a partial agonist of D2-receptor with selectivity for β-Arrestin over cAMP signal pathways. Synthesis of this derivative was selected based on high potency, and therefore need for lower product yield to be utilized for further testing of antipsychotic effects in C. Elegans as model organisms

This document is currently not available here.

Share

COinS
 
Apr 17th, 4:00 PM Apr 17th, 4:45 PM

Synthesis of B-Arrestin D2 Biased Dopamine Agonist

2nd floor - Library

Aripiprazole is one of the most commonly prescribed antipsychotic drugs on the market that relies on dopamine receptor agonism as the mechanism of action. Derivatives of this compound including 7-(4-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)butoxy)-3,4-dihydroquinolin-2 (1H)-one, have been studied and found to be a partial agonist of D2-receptor with selectivity for β-Arrestin over cAMP signal pathways. Synthesis of this derivative was selected based on high potency, and therefore need for lower product yield to be utilized for further testing of antipsychotic effects in C. Elegans as model organisms